• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Caprotec Bioanalytics

edit

caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.

caprotec’s Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

Recent Milestones

edit

• 
  Caprotec Bioanalytics — increased its Series B funding round to $7.2 million (5/9/11)
  Posted 5/10/11 at 2:59am via masshightech.com
• 
  Caprotec Bioanalytics received $2.1M in Series B funding. (5/9/11)
  Posted 5/9/11 at 6:04pm via masshightech.com
• 
  Caprotec Bioanalytics — Names new managing director (10/4/10)
  Posted 10/4/10 at 8:20am via masshightech.com
• 
  Caprotec Bioanalytics received $5.1M in Series B funding. (5/13/10)
  Posted 5/19/10 at 6:30pm via caprotec.com
• 
  Caprotec Bioanalytics received $8.8M in Venture Round funding. (1/10/08)
  Posted 3/15/10 at 6:43pm via caprotec.com
• 
  Caprotec Bioanalytics added Dr. Jonathan Turner as CEO.
  Posted 10/19/12 at 9:49pm

Videos

Screenshots

edit

Above: caprotec bioanalytics
Uploaded: 3/16/10

Sources

1. Life Science Startup Caprotec Bioanalytics Receives Additional Venture Capital Funding (caprotec.com) [edit]
2. caprotec bioanalytics Completes Series B Financing Round of EUR 4 Million (caprotec.com) [edit]
3. Caprotec bioanalytics bumps funding up to $7.2M (masshightech.com) [edit]
Caprotec bioanalytics names Metternich managing director (masshightech.com) [edit]
Caprotec bioanalytics bumps funding up to $7.2M (masshightech.com) [edit]